Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosis

Mayo Clinic Proceedings

Volumn 79, Issue 8, 2004, Pages 1024-1030

  Svobodník, Adam ^a,b   Yang, Ping ^a   Novotny, Paul J ^a   Bass, Eric ^a   Garces, Yolanda I ^a   Jett, James R ^a   Bonner, James A ^a,c   Sloan, Jeff A ^a  

^a Mayo Clinic   (United States)

^b MASARYK UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APPETITE; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COUGHING; DYSPNEA; FATIGUE; FEMALE; FOLLOW UP; GENDER; HEMOPTYSIS; HISTOLOGY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PAIN; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; VISUAL ANALOG SCALE; WEIGHT REDUCTION;

EID: 3442878382     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.8.1024     Document Type: Article

References (35)

1. Montazeri A, Gillis CR, McEwen J. Quality of life in patients with lung cancer: a review of literature from 1970 to 1995. Chest. 1998;113:467-481.
2. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-376.
3. Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M, EORTC Study Group on Quality of Life. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer. 1994;30A:635-642.
4. Hollen PJ, Gralla RJ, Kris MG, Potanovich LM. Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer. 1993;29A(suppl 1):S51-S58.
5. Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer. 1995;12:199-220.
6. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological Typing of Lung and Pleural Tumours. 3rd ed. New York, NY: Springer-Verlag; 1999:21-47.
7. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997;111:1710-1717.
8. Visbal AL, Williams BA, Nichols FC III, et al. Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg. 2004;78:209-215.
9. Yang P, Yokomizo A, Tazelaar HD, et al. Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes. Lung Cancer. 2002;35:221-229.
10. 1-antitrypsin deficiency allele carriers in lung cancer patients. Cancer Epidemiol Biomarkers Prev. 1999;8:461-465.
11. Hollen PJ, Gralla RJ, Kris MG, Eberly SW, Cox C. Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS). Support Care Cancer. 1999;7:140-148.
12. Hollen PJ, Gralla RJ. Comparison of instruments for measuring quality of life in patients with lung cancer. Semin Oncol. 1996;23(2, suppl 5):31-40.
13. Hollen PJ, Gralla RJ, Kris MG, et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies: psychometric assessment of the Lung Cancer Symptom Scale. Cancer. 1994;73:2087-2098.
14. Klastersky J, Paesmans M. Response to chemotherapy, quality of life benefits and survival in advanced non-small cell lung cancer: review of literature results. Lung Cancer. 2001;34(suppl 4):S95-S101.
15. Hollen PJ, Gralla RJ, Cox C, Eberly SW, Kris MG. A dilemma in analysis: issues in the serial measurement of quality of life in patients with advanced lung cancer. Lung Cancer. 1997;18:119-136.
16. 2 dose of docetaxel with prednisone premedication for patients with advanced nonsmall cell lung cancer. Cancer. 1995;75:968-972.
17. Lutz ST, Huang DT, Ferguson CL, Kavanagh BD, Tercilla OF, Lu J. A retrospective quality of life analysis using the Lung Cancer Symptom Scale in patients treated with palliative radiotherapy for advanced nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 1997;37:117-122.
18. Comella P, Frasci G, Panza N, et al. Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group. J Clin Oncol. 1999;17:1526-1534.
19. Frasci G, Lorusso V, Panza N, et al. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol. 2000;18:2529-2536.
20. Comella P, Frasci G, Panza N, et al. Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology Group. J Clin Oncol. 2000;18:1451-1457.
21. Sloan JA, Cella D, Frost M, Guyatt GH, Sprangers M, Symonds T, Clinical Significance Consensus Meeting Group. Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc. 2002;77:367-370.
22. Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York, NY: McGraw-Hill; 1994.
23. Gridelli C, Perrone F, Nelli F, Ramponi S, De Marinis F. Quality of life in lung cancer patients. Ann Oncol. 2001;12(suppl 3):S21-S25.
24. Fernandez C, Rosell R, Abad-Esteve A, et al. Quality of life during chemotherapy in non-small cell lung cancer patients. Acta Oncol. 1989;28:29-33.
25. Shepherd FA, Dancey D, Ramlau R, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol. 2000;18:2095-2103.
26. Finkelstein DM, Cassileth BR, Bonomi PD, Ruckdeschel JC, Ezdinli EZ, Wolter JM. A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients: an Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1988;11:630-633.
27. Wolf M, Pritsch M, Drings P, et al. Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients. J Clin Oncol. 1991;9:614-624.
28. Langendijk JA, Aaronson NK, ten Velde GP, de Jong JM, Muller MJ, Wouters EF. Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy. Acta Oncol. 2000;39:949-958.
29. Herndon JE II, Fleishman S, Kornblith AB, Kosty M, Green MR, Holland J. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer. 1999;85:333-340.
30. Herndon JE II, Fleishman S, Kosty MP, Green MR. A longitudinal study of quality of life in advanced non-small cell lung cancer: Cancer and Leukemia Group B (CALGB) 8931. Control Clin Trials. 1997;18:286-300.
31. Kaasa S, Mastekaasa A. Psychosocial well-being of patients with inoperable non-small cell lung cancer: the importance of treatment- and disease-related factors. Acta Oncol. 1988;27(6b):829-835.
32. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer. 2001;31: 233-240.
33. Ruckdeschel JC, Piantadosi S. Quality of life in lung cancer surgical adjuvant trials. Chest. 1994;106(6, suppl):324S-328S.
34. Schwartz CE, Sendor M. Helping others helps oneself: response shift effects in peer support. Social Sci Med. 1999;48:1563-1575.
35. Garces YI, Yang P, Parkinison J, et al. Does cigarette smoking have an impact on quality of life after diagnosis of lung cancer? Chest. In press.